Anti‐inflammatory, antiapoptotic, and antioxidant activity of fluoxetine
Authors:
Open Access
- 7 April 2016
- journal article
- review article
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 4 (3) , e00231
Abstract
Fluoxetine is a selective serotonin uptake inhibitor that has been widely used to determine the neurotransmission of serotonin in the central nervous system. This substance has emerged as the drug of choice for the treatment of depression due to is safer profile, fewer side effects, and greater tolerability. Studies have found the following important functions of fluoxetine related to the central nervous system: neuroprotection; anti‐inflammatory properties similar to standard drugs for the treatment of inflammatory conditions; antioxidant properties, contributing to its therapeutic action and an important intracellular mechanism underlying the protective pharmacological effects seen in clinical practice in the treatment of different stress‐related adverse health conditions; and antiapoptotic properties, with greater neuron survival and a reduction in apoptosis mediators as well as oxidative substances, such as superoxide dismutase and hydrogen peroxide. The aim of this study was to perform a review of the literature on the important role of fluoxetine in anti‐inflammatory, cell survival, and neuron trophicity mechanisms (antiapoptotic properties) as well as its role regarding enzymes of the antioxidant defense system.Keywords
This publication has 83 references indexed in Scilit:
- Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stressJournal of Psychiatric Research, 2012
- Fluoxetine protects neurons against microglial activation-mediated neurotoxicityParkinsonism & Related Disorders, 2012
- Effects of Fluoxetine Treatment on Striatal Dopamine Transporter Binding and Cerebrospinal Fluid Insulin-Like Growth Factor-1 in Children with AutismNeuropediatrics, 2011
- Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain‐derived neurotrophic factor, β‐catenin and antidepressant‐like effectsBritish Journal of Pharmacology, 2011
- From synapse to nucleus: Novel targets for treating depressionNeuropharmacology, 2010
- Neuroanatomical Pattern of Mitochondrial Complex I Pathology Varies between Schizophrenia, Bipolar Disorder and Major DepressionPLOS ONE, 2008
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- Moclobemide upregulated Bcl‐2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular‐regulated kinase pathwayBritish Journal of Pharmacology, 2006
- Effects of quetiapine on the brain-derived neurotrophic factor expression in the hippocampus and neocortex of ratsNeuroscience Letters, 2006
- Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cellsBlood, 2003